Maxcyte (MXCT)HHS awarded $126K

$126K

committed so far

Signed

Mar 25, 2026

Updated

Mar 25, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 16, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On March 16, 2026, MaxCyte, Inc. (the “Company”) received notice (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company’s common stock had fallen below $1.00 per share for 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market…”
2. Mar 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 23, 2026, the Board of Directors (the “ Board ”) of MaxCyte, Inc. (the “ Company ”) appointed Parmeet Ahuja as the Company’s Chief Financial Officer, effective March 30, 2026.”
3. Mar 24, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
4. Mar 25, 2026 · this disclosureFederal contract · $126K obligatedDepartment of Health and Human Services awarded MAXCYTE, INC.: $126K obligated to date

What came next

1. May 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Jun 10, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“; Transfer of Listing As previously disclosed on a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 20, 2026, on March 16, 2026, MaxCyte, Inc. (the “Company”) received notice from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) that, because the closing bid price for the Company’s common stock had fallen below $1.00 per share for 30 consecutive trading…”

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for Maxcyte

For Maxcyte, OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MXCT page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at Maxcyte

• USAspending.gov award recordAug 31, 2026
• SEC Form 4Aug 27, 2025
• SEC Form 4Aug 13, 2025
• SEC Form 4Aug 13, 2025
• SEC Form 4Aug 13, 2025
• SEC Form 4Aug 13, 2025

Everything OQRO holds on this company is on its MXCT page.